Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza
BACKGROUND: New prophylactic and therapeutic strategies to combat human infections with highly pathogenic avian influenza (HPAI) H5N1 viruses are needed. We generated neutralizing anti-H5N1 human monoclonal antibodies (mAbs) and tested their efficacy for prophylaxis and therapy in a murine model of...
Uložené v:
| Hlavný autor: | |
|---|---|
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
2018
|
| On-line prístup: | https://demo7.dspace.org/handle/123456789/134 |
| Tagy: |
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|